Showing results (241-250 of 363) with videos related to

Sort By:
Pageof 37
European Urology Oncology|October 23, 2018
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer PatientsStephen B Williams, Ashish M Kamat, Karim Chamie, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 12, 2017
Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspectiveKeith A Lawson, Olli Saarela, Zhihui Liu, et al.
Urologic Oncology|July 18, 2016
Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancerConnor M Forbes, Ricardo A Rendon, Antonio Finelli, et al.
Clinical Genitourinary Cancer|August 13, 2020
Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment ModalitiesMarina Deuker, Thomas Martin, Franziska Stolzenbach, et al.
Cell Death Discovery|August 15, 2020
A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urineThomas Mandel Clausen, Gunjan Kumar, Emilie K Ibsen, et al.
European Urology|February 1, 2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysisZhenjie Wu, Qi Chen, Le Qu, et al.
Scientific Reports|May 20, 2022
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabineShigehiro Tsukahara, Masaki Shiota, Dai Takamatsu, et al.
Bioconjugate Chemistry|January 19, 2026
A Modular Method for Rapidly Prototyping Targeted Gas Vesicle Protein NanoparticlesReid Vassallo, Bill Ling, Ernesto Criado-Hidalgo, et al.
The Journal of Urology|May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-GuérinHenning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Cancer Causes & Control : CCC|June 14, 2022
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic reviewElliott Freudenburg, Iyla Bagheri, Sunay Srinivas, et al.
Pageof 37